305 related articles for article (PubMed ID: 36172197)
1. Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases.
Yang F; Xue J; Wang G; Diao Q
Front Pharmacol; 2022; 13():999404. PubMed ID: 36172197
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle Based Treatment for Cardiovascular Diseases.
Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
[TBL] [Abstract][Full Text] [Related]
3. Nanodrugs as a New Approach in the Therapy of Cardiovascular Diseases and Cancer with Tumor-associated Angiogenesis.
Hajtuch J; Niska K; Inkielewicz-Stepniak I
Curr Med Chem; 2021; 28(27):5527-5550. PubMed ID: 33390102
[TBL] [Abstract][Full Text] [Related]
4. Nitric Oxide Nano-Delivery Systems for Cancer Therapeutics: Advances and Challenges.
Vong LB; Nagasaki Y
Antioxidants (Basel); 2020 Aug; 9(9):. PubMed ID: 32858970
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
Mohamed NA; Marei I; Crovella S; Abou-Saleh H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-based therapeutic strategies for mitochondrial dysfunction in cardiovascular disease.
Suzuki I; Xing H; Giblin J; Ashraf A; Chung EJ
J Biomed Mater Res A; 2024 Jun; 112(6):895-913. PubMed ID: 38217313
[TBL] [Abstract][Full Text] [Related]
8. Disposition of nanoparticle-based delivery system via inner ear administration.
Chen G; Zhang X; Yang F; Mu L
Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
[TBL] [Abstract][Full Text] [Related]
9. Recent Developments in Nanomaterial Drug Delivery and Upgrading Treatment of Cardiovascular Disease.
Khan J; Yadav S; Alam MA
Curr Pharm Des; 2023 Nov; ():. PubMed ID: 37916494
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
11. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
14. The physiology of cardiovascular disease and innovative liposomal platforms for therapy.
Ruiz-Esparza GU; Flores-Arredondo JH; Segura-Ibarra V; Torre-Amione G; Ferrari M; Blanco E; Serda RE
Int J Nanomedicine; 2013; 8():629-40. PubMed ID: 23413209
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16.
Cevaal PM; Ali A; Czuba-Wojnilowicz E; Symons J; Lewin SR; Cortez-Jugo C; Caruso F
ACS Nano; 2021 Mar; 15(3):3736-3753. PubMed ID: 33600163
[TBL] [Abstract][Full Text] [Related]
17. Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis.
Liu H; Pietersz G; Peter K; Wang X
J Nanobiotechnology; 2022 Feb; 20(1):75. PubMed ID: 35135581
[TBL] [Abstract][Full Text] [Related]
18. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders.
Mittal R; Patel AP; Jhaveri VM; Kay SS; Debs LH; Parrish JM; Pan DR; Nguyen D; Mittal J; Jayant RD
Expert Opin Drug Deliv; 2018 Mar; 15(3):301-318. PubMed ID: 29272976
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in prodrug-based nanoparticle therapeutics.
Chen KJ; Plaunt AJ; Leifer FG; Kang JY; Cipolla D
Eur J Pharm Biopharm; 2021 Aug; 165():219-243. PubMed ID: 33979661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
